POU2AF2
POU domain class 2-associating factor 2
Also known as: C11orf53, MGC50104, OCA-T1, OCAT1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IXP5
- Gene
- POU2AF2
- Ensembl
- ENSG00000150750
- Chromosome
- 11
- Canonical length
- 288 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles
OverviewNCBI Gene
Enables sequence-specific DNA binding activity and transcription coactivator activity. Predicted to be involved in positive regulation of DNA-templated transcription. Located in nucleus. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
288 residues, UniProt reviewed canonical sequence.
>Q8IXP5|POU2AF2
1 MESVPGDYSK RVYQGVRVKH TVKDLLAEKR SGQTSNSRLN GSVSSSQSPF VQMPGSPVTS
61 GYYGVRRSFL SDSDFHNSKQ FSNDVYTSSV GKPFPCESSA GQSHAALLEP YFPQEPYGDY
121 RPPALTPNAG SLFSASPLPP LLPPPFPGDP AHFLFRDSWE QTLPDGLSQP DPVSADALLT
181 LPPSTSCLSQ LESGSIAQHR GSSWGSSLAG AQSYSLHALE DLHHTPGYPT PPPYPFTPFM
241 TVSNDLPPKV GPLSPDEEAD TGSLHDPSPW VKEDGSIAWG SYECRRAYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against POU2AF2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.71
- Highest tissue expression
- 4.9 nTPM
Expression across tissuesHPA
Tissue
- testis: 4.9 nTPM
- stomach: 2.9 nTPM
- breast: 2.4 nTPM
- salivary gland: 2 nTPM
- skeletal muscle: 1.7 nTPM
- colon: 1.3 nTPM
Single-cell type
- tuft cells: 219 nCPM
- late primary spermatocytes: 60 nCPM
- early spermatids: 14 nCPM
- cholangiocytes: 14 nCPM
- epididymal clear cells: 12 nCPM
- late spermatids: 10 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
- midbrain: 0.1 nTPM
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.36
- gnomAD pLI
- 0
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- OCA domain
- POU domain class 2-associating factor 2
- POU domain class 2-associating factor 2
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of POU2AF2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads POU2AF2 as an antibody target. Whether an autoantibody or antibody against POU2AF2 could matter depends on whether native POU2AF2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
POU2AF2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label POU2AF2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...